CHICAGO — Pretreatment evaluation of fat-to-muscle ratio in thyroid eye disease will allow for the best treatment choice, a presenter here said.
“We found that those with a low fat-to-muscle ratio had similar levels of proptosis reduction with teprotumumab as compared to surgical decompression,” Michelle Ting, MA (Cantab), FRCOphth, of the Shiley Eye Institute at UC San Diego, said at the ASOPRS Fall Scientific Symposium. “By contrast, in patients with a high fat-to-muscle ratio, it appears that orbital decompression is associated with a greater level of reduction in